APA citiranje

S, R. E., D, M. R., Joanna, S., P, B. S., & WL, K. J. (2011). A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study. BMC.

Citação norma Chicago

S, Rogers Elaine, MacLeod Roderick D, Stewart Joanna, Bird Stephen P, and Keogh Justin WL. A Randomised Feasibility Study of EPA and Cox-2 Inhibitor (Celebrex) Versus EPA, Cox-2 Inhibitor (Celebrex), Resistance Training Followed By Ingestion of Essential Amino Acids High in Leucine in NSCLC Cachectic Patients - ACCeRT Study. BMC, 2011.

MLA citiranje

S, Rogers Elaine, et al. A Randomised Feasibility Study of EPA and Cox-2 Inhibitor (Celebrex) Versus EPA, Cox-2 Inhibitor (Celebrex), Resistance Training Followed By Ingestion of Essential Amino Acids High in Leucine in NSCLC Cachectic Patients - ACCeRT Study. BMC, 2011.